Cargando…
Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostig...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983073/ https://www.ncbi.nlm.nih.gov/pubmed/31947900 http://dx.doi.org/10.3390/molecules25010211 |
_version_ | 1783491435875532800 |
---|---|
author | Bosak, Anita Bavec, Aljoša Konte, Tilen Šinko, Goran Kovarik, Zrinka Goličnik, Marko |
author_facet | Bosak, Anita Bavec, Aljoša Konte, Tilen Šinko, Goran Kovarik, Zrinka Goličnik, Marko |
author_sort | Bosak, Anita |
collection | PubMed |
description | Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostigmine are drugs, carbofuran is used as a pesticide, while Ro 02-0683 is diagnostic reagent. All the selected carbamates reduced the arylesterase activity of rePON1 towards the substrate S-phenyl thioacetate (PTA). Inhibition dissociation constants (K(i)), evaluated by both discontinuous and continuous inhibition measurements (progress curves), were similar and in the mM range. The rePON1 displayed almost the same values of K(i) constants for Ro 02-0683 and physostigmine while, for carbofuran and bambuterol, the values were approximately ten times lower and two times higher, respectively. The affinity of rePON1 towards the tested carbamates was about 3–40 times lower than that of PTA. Molecular modelling of rePON1-carbamate complexes suggested non-covalent interactions with residues of the rePON1 active site that could lead to competitive inhibition of its arylesterase activity. In conclusion, carbamates can reduce the level of PON1 activity, which should be kept in mind, especially in medical conditions characterized by reduced PON1 levels. |
format | Online Article Text |
id | pubmed-6983073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69830732020-02-06 Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates Bosak, Anita Bavec, Aljoša Konte, Tilen Šinko, Goran Kovarik, Zrinka Goličnik, Marko Molecules Article Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostigmine are drugs, carbofuran is used as a pesticide, while Ro 02-0683 is diagnostic reagent. All the selected carbamates reduced the arylesterase activity of rePON1 towards the substrate S-phenyl thioacetate (PTA). Inhibition dissociation constants (K(i)), evaluated by both discontinuous and continuous inhibition measurements (progress curves), were similar and in the mM range. The rePON1 displayed almost the same values of K(i) constants for Ro 02-0683 and physostigmine while, for carbofuran and bambuterol, the values were approximately ten times lower and two times higher, respectively. The affinity of rePON1 towards the tested carbamates was about 3–40 times lower than that of PTA. Molecular modelling of rePON1-carbamate complexes suggested non-covalent interactions with residues of the rePON1 active site that could lead to competitive inhibition of its arylesterase activity. In conclusion, carbamates can reduce the level of PON1 activity, which should be kept in mind, especially in medical conditions characterized by reduced PON1 levels. MDPI 2020-01-04 /pmc/articles/PMC6983073/ /pubmed/31947900 http://dx.doi.org/10.3390/molecules25010211 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bosak, Anita Bavec, Aljoša Konte, Tilen Šinko, Goran Kovarik, Zrinka Goličnik, Marko Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title | Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title_full | Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title_fullStr | Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title_full_unstemmed | Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title_short | Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates |
title_sort | interactions of paraoxonase-1 with pharmacologically relevant carbamates |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983073/ https://www.ncbi.nlm.nih.gov/pubmed/31947900 http://dx.doi.org/10.3390/molecules25010211 |
work_keys_str_mv | AT bosakanita interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates AT bavecaljosa interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates AT kontetilen interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates AT sinkogoran interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates AT kovarikzrinka interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates AT golicnikmarko interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates |